CN Patent

CN101528227A — 氮杂环丁酮衍生物及其使用方法

Assigned to Merck Sharp and Dohme LLC · Expires 2009-09-09 · 17y expired

What this patent protects

本发明涉及治疗或预防脂质代谢障碍、疼痛、糖尿病、血管病症、脱髓鞘作用或非酒精性脂肪肝疾病的方法，该方法包括施用式(I)的化合物或其药学可接受的盐、溶剂合物、酯、前药或立体异构体，其中R 1 和R 2 定义于本文表1－6中，并且R 3 为－苯基、－4－氯苯基、－2－吡啶基或－3－吡啶基。

USPTO Abstract

本发明涉及治疗或预防脂质代谢障碍、疼痛、糖尿病、血管病症、脱髓鞘作用或非酒精性脂肪肝疾病的方法，该方法包括施用式(I)的化合物或其药学可接受的盐、溶剂合物、酯、前药或立体异构体，其中R 1 和R 2 定义于本文表1－6中，并且R 3 为－苯基、－4－氯苯基、－2－吡啶基或－3－吡啶基。

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CN101528227A
Jurisdiction: CN
Classification: —
Expires: 2009-09-09
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.